| scholarly article | Q13442814 |
| P2093 | author name string | B Ljung | |
| P2860 | cites work | Nifedipine and left ventricular function in beta-blocked patients | Q36780379 |
| Studies with isolated human coronary arteries. Some general observations, potential mediators of spasm, role of calcium antagonists | Q41480768 | ||
| Some effects of sodium nitroprusside, methoxyverapamil (D600) and nifedipine on rat portal vein | Q42020793 | ||
| Dependence on external calcium for the noradrenaline contractility of the resistance vessels in spontaneously hypertensive and renal hypertensive rats, as compared with normotensive controls | Q43537615 | ||
| Effects of calcium-antagonistic coronary vasodilators on myocardial contractility and membrane potentials | Q46832010 | ||
| Calcium antagonist receptor binding sites labeled with [3H]nitrendipine | Q49017121 | ||
| [A new group of competitive divalent Ca-antagonists (iproveratril, D 600, prenylamine) with potent inhibitory effects on electromechanical coupling in mammalian myocardium] | Q54073509 | ||
| Haemodynamic effects of short and long term administration of felodipine in spontaneously hypertensive rats. | Q54457507 | ||
| Acute haemodynamic effects of felodipine in patients with coronary artery disease. | Q54457509 | ||
| Effects of felodipine on renal function in animals. | Q54457525 | ||
| Effect of felodipine, a new dihydropyridine vasodilator, on contractile responses to potassium, noradrenaline, and calcium in mesenteric resistance vessels of the rat. | Q54475714 | ||
| Contractility, muscle mass and agonist sensitivity of isolated portal veins from normo- and hypertensive rats. | Q54598637 | ||
| A further Contribution regarding the influence of the different Constituents of the Blood on the Contraction of the Heart | Q58717709 | ||
| Interaction of the antihypertensive drug felodipine with calmodulin | Q59062205 | ||
| Electrical and Mechanical Activity of Isolated Vascular Smooth Muscle of the Rat | Q59096022 | ||
| [Electromechanical uncoupling of vascular smooth muscle as the basic principle of coronary dilatation by 4-(2'-nitrophenyl-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester (BAY a 1040, Nifedipine). 1. The significance of Ca ++ | Q69373517 | ||
| Pharmacologic properties of minoxidil: a new hypotensive agent | Q69381505 | ||
| Antihypertensive effects of felodipine compared with placebo | Q69860461 | ||
| The mechanism of inhibitory action of diltiazem on vascular smooth muscle contractility | Q70833074 | ||
| Cardiovascular actions of the calmodulin inhibitor felodipine | Q71079198 | ||
| Calcium antagonistic drugs. Mechanism of action | Q71208102 | ||
| Calcium and calmodulin antagonists binding to calmodulin and relaxation of coronary segments | Q71799351 | ||
| Influence of the lonic Environment on Spontaneous Electrical and Mechanical Activity of the Rat Portal Vein | Q72350486 | ||
| COMPARATIVE EFFECTS OF HYDRALAZINE, SODIUM NITRITE AND ACETYLCHOLINE ON RESISTANCE AND CAPACITANCE BLOOD VESSELS AND CAPILLARY FILTRATION IN SKELETAL MUSCLE IN THE CAT | Q76602811 | ||
| DESCRIPTION OF THE MYOGENIC HYPOTHESIS | Q76946346 | ||
| Determination of felodipine in plasma by capillary gas chromatography with electron capture detection | Q79987083 | ||
| P304 | page(s) | 46-58 | |
| P577 | publication date | 1985-01-01 | |
| P1433 | published in | Drugs | Q3040094 |
| P1476 | title | Vascular selectivity of felodipine. | |
| P478 | volume | 29 Suppl 2 |
| Q39685266 | 'Second generation' dihydropyridine calcium antagonists. Greater vascular selectivity and some unique applications |
| Q51600896 | Absorption, gastrointestinal transit, and tablet erosion of felodipine extended-release (ER) tablets. |
| Q68859224 | Acute effects of felodipine and nifedipine on hepatic and forearm blood flow in healthy men |
| Q64976030 | Acute renal effects of oral felodipine in normal man. |
| Q68687162 | Antihypertensive and biochemical effects of the dihydropyridine felodipine in the long term treatment of moderate to severe hypertension |
| Q69928690 | Antihypertensive efficacy of the calcium-antagonist felodipine in patients with persisting hypertension on beta-adrenoceptor blocker therapy. The Canadian Felodipine Study Group |
| Q39697150 | Aspects on the benefit-risk balance of felodipine in hypertension |
| Q42049235 | Attenuation of renal ischaemic injury by felodipine |
| Q42212914 | Baroreflex control of renin release in spontaneously hypertensive rats after administration of felodipine. |
| Q71617090 | Beneficial effects of felodipine on myocardial and coronary function during low-flow ischemia and reperfusion |
| Q39341746 | Calcium channel antagonists, Part I: Fundamental properties: mechanisms, classification, sites of action |
| Q39613016 | Calcium channel antagonists. Part V: Second-generation agents |
| Q38216387 | Calcium channel antagonists: Part VI: Clinical pharmacokinetics of first and second-generation agents |
| Q54308602 | Central and peripheral haemodynamic responses to felodipine in congestive heart failure |
| Q71149767 | Clinical equivalence of two tablet formulations of felodipine. A placebo-controlled study of 24-hour blood pressure control and tolerability |
| Q39697154 | Clinical pharmacokinetics of felodipine. A summary |
| Q47913024 | Clinical pharmacokinetics of vasodilators. Part I. |
| Q68687153 | Comparison of antihypertensive effect and pharmacokinetics of conventional and extended release felodipine tablets in patients with arterial hypertension |
| Q34357849 | Control of blood pressure in hypertensive patients with felodipine extended release or nifedipine retard |
| Q68230760 | Effects of felodipine and metoprolol on blood pressure, plasma renin, angiotensin II, aldosterone and catecholamines in hypertensive patients |
| Q49289763 | Efficacy and tolerability of felodipine ER and diltiazem SR as monotherapy in primary hypertension: a double-blind randomized study |
| Q34118763 | Efficacy of felodipine in chronic congestive heart failure: a placebo controlled haemodynamic study at rest and during exercise and orthostatic stress |
| Q28325479 | Felodipine Clinical Pharmacokinetics |
| Q28332845 | Felodipine ER formulation in the treatment of mild hypertension: efficacy and tolerability vs placebo |
| Q28323113 | Felodipine in combination with a beta-adrenoceptor blocker as an effective substitute for triple therapy in severe hypertension. The Australian Felodipine Multicentre Study Group |
| Q69928385 | Felodipine in hypertension |
| Q34118531 | Felodipine in patients with chronic heart failure: discrepant haemodynamic and clinical effects |
| Q54099334 | Felodipine in the treatment of patients with severe hypertension and impaired renal function. |
| Q68230773 | Felodipine monotherapy in systolic hypertension in the elderly |
| Q68166920 | Felodipine prevents the poststenotic myocardial ischemia induced by alpha 2-adrenergic coronary constriction |
| Q69665183 | Felodipine reduces the absorption of theophylline in man |
| Q69915058 | Felodipine versus prazosin as an addition to a beta-blocker in the treatment of essential hypertension. The Australian Multicentre Study |
| Q69885547 | Felodipine vs hydralazine: a controlled trial as third line therapy in hypertension. Cooperative Study Group |
| Q69915064 | Felodipine, a new calcium antagonist, as monotherapy in mild or moderate hypertension. Cooperative study group |
| Q39567108 | Felodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension |
| Q43176871 | Glucose tolerance in hypertensive patients during treatment with the calcium antagonist, felodipine |
| Q69406104 | Haemodynamic effects and pharmacokinetics of felodipine at rest and during exercise in hypertensive patients treated with metoprolol or atenolol |
| Q68687187 | Haemodynamic effects of felodipine in congestive heart failure |
| Q67269581 | Hemodynamic effects of felodipine in congestive heart failure |
| Q70259509 | Hemodynamic interactions between diuretics and calcium antagonists in the treatment of hypertensive patients |
| Q69915074 | Hormonal and blood pressure responses to tilting in beta-blocked essential hypertension treated with felodipine or prazosin |
| Q40780507 | Hypertension in the elderly: age- and disease-related complications and therapeutic implications |
| Q41727941 | Interaction of dihydropyridine calcium channel agonists and antagonists with adenosine receptors |
| Q37858050 | Isradipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease |
| Q52614145 | Metabolism of [14C] felodipine, a new vasodilating drug, in healthy volunteers. |
| Q72164962 | Natriuretic and diuretic effects of felodipine and hydrochlorothiazide after single and repeated doses |
| Q70212964 | Once daily felodipine in patients with primary Raynaud's phenomenon |
| Q39697161 | Pharmacodynamic properties of felodipine |
| Q68448575 | Pharmacokinetics and blood pressure effects of felodipine in elderly hypertensive patients. A comparison with young healthy subjects |
| Q54311400 | Pharmacokinetics and hemodynamic and diuretic/natriuretic effects of felodipine administered as an extended-release tablet. |
| Q34397822 | Pharmacokinetics of felodipine after intravenous and chronic oral administration in patients with congestive heart failure |
| Q68687176 | Pharmacokinetics of felodipine and effect on digoxin plasma levels in patients with heart failure |
| Q42277034 | Pharmacokinetics of felodipine in patients with impaired renal function |
| Q42646696 | Pharmacokinetics of felodipine in patients with liver disease |
| Q68769516 | Renal failure in haemorrhagic shock in dogs: salutary effects of the calcium entry blocker felodipine |
| Q54385455 | Restoration of renal and mesenteric hemodynamics by felodipine in a canine model of hemorrhagic shock |
| Q54449659 | Studies on the effects of felodipine on the vascular resistance and reactivity in pentobarbital anesthetized dogs. |
| Q72753409 | The acute haemodynamic and renal effects of oral felodipine and ramipril in healthy subjects |
| Q69541337 | The clinical effect of felodipine and nifedipine in Raynaud's phenomenon |
| Q68346771 | The effects of felodipine in angina pectoris |
| Q54337374 | The haemodynamic effects of long term felodipine therapy in previously untreated essential hypertension. |
| Q68877420 | Treatment of essential hypertension with felodipine in combination with a diuretic |
| Q52058446 | Twenty-four hour profile of the hypotensive action of felodipine in essential hypertension |
| Q40393261 | Vascular Versus Myocardial Effects of Calcium Antagonists |
| Q40952727 | Vascular selective calcium entry blockers in the treatment of cardiovascular disorders: focus on felodipine |
Search more.